RxDoctor Payments Data

Ananth Vellimana, MD

Neurological Surgery · Saint Louis, MONPI 1144583113

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (36.5%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Penumbra, Inc. at 53.0% of the total. 2025 is the largest year on record at $8,882, more than ten times the $100 reported in 2019.

$28,282in general payments, 2019–2025

Across 91 payments — averaging $310.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$15K
  • Medical Device Business Services, Inc.$9K
  • Aesculap, Inc.$1K
  • Stryker$1K
  • Silk Road Medical, Inc.$639
  • Medtronic$388
  • plus $791 from 6 others
$12,420in research payments, 2019–2025

Across 3 payments — averaging $4140.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Microvention, Inc.$12K

What the payments were for

  • Consulting fees$4,50016%
  • Speaking & faculty fees$9,60034%
  • Travel & lodging$10,33137%
  • Food & beverage$3,85114%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,282 in reported general payments places this provider in the 85th percentile of 172 neurological surgery providers in Missouri.

See all neurological surgery providers in Missouri

Medicare billing

Part B allowed, 2024
$226,770
Medicare patients
261
Services billed
1,097

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor41$19,393
Carbamazepine27$577
Levetiracetam16$331
Gabapentin25$323
Mupirocin24$159
ClopidogrelClopidogrel Bisulfate41$107
Topiramate17$89

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →